CASE STUDY:
Solvay Pharmaceuticals, Inc. is the U.S. subsidiary of the research driven group of pharmaceutical companies. In this case study learn how the implementation of VMware infrastructure increased scalability and performance in the datacenter.
WHITE PAPER:
This paper addresses new market forces that are compelling them to consider a range of alternatives, including outsourcing and offshore opportunities.
CASE STUDY:
Learn how Kalypsis, a clinical stage pharmaceutical company, is leveraging Xerox DocuShare Enterprise Content Management to control content for regulatory operations and clinical trials.
WHITE PAPER:
This paper explores how by collaborating and sharing data, the two industries can realize the full value of the information they collect--and improve patient treatments.
WHITE PAPER:
This paper addresses new market forces that are compelling them to consider a range of alternatives, including outsourcing and offshore opportunities.
EZINE:
In this week's Computer Weekly, we find out how new technologies are supporting the rise of vertical farming, and could revolutionise food supply chains. We examine one of the biggest trends in the cloud – serverless computing. And Brexit has not yet ended the debate about UK-EU data protection. Read the issue now.
ESSENTIAL GUIDE:
This 5 page special report from Computer Weekly gives you the facts on Wipro, its strategy, products and services and financial performance.
WHITE PAPER:
This paper provides practical industry insights on IFRS for life science executives and includes useful sections on: IFRS challenges and opportunities in life sciences; Implications of IFRS for financial reporting, tax, human resources, mergers and acquisitions, IT, and treasury and much more.
WHITE PAPER:
SAS technology has been proven to be the most versatile storage solution in data transfer and high performance. Read this white paper to learn about a solution that renders the necessary performance needed for your client's expanding market requirements.
WHITE PAPER:
This study of over 150 Fortune 1000 firms from every major industry or vertical explores issues associated with the lifeblood of today’s enterprises: data. The findings demonstrate the often dramatic impacts that even marginal investments in information technology can have when that technology addresses data quality, usability, and intelligence.
